Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Literature
1.
Pandit H, Glyn-Jones S, McLardy-Smith P, Gundle R, Whitwell D, Gibbons CLM et al (2008). Pseudotumours associated with metal-on-metal hip resurfacings. J Bone Joint Surg Br 90-B:847–851
2.
Willert HG, Buchhorn GH, Fayyazi A, Flury R, Windler M, Köster G et al (2005) Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study. J Bone Joint Surg Am 87:28–36PubMedCrossRef
3.
Boardman DR, Middleton FR, Kavanagh TG (2006) A benign psoas mass following metal-on-metal resurfacing of the hip. J Bone Joint Surg Br 88-B:402–404
4.
Jacobs JJ, Hallab NJ (2006) Loosening and osteolysis associated with metal-on-metal bearings: a local effect of metal hypersensitivity? J Bone Joint Surg Am 88:1171–1172PubMedCrossRef
5.
Daniel J, Ziaee H, Pradhan C, McMinn DJW (2009) Six-year results of a prospective study of metal ion levels in young patients with metal-on-metal hip resurfacings. J Bone Joint Surg Br 91-B:176–179
6.
Langton DJ, Jameson SS, Joyce TJ, Webb J, Nargol AVF (2008) The effect of component size and orientation on the concentrations of metal ions after resurfacing arthroplasty of the hip. J Bone Joint Surg Br 90-B:1143–1151CrossRef
7.
Langton DJ, Sprowson AP, Joyce TJ, Reed M, Carluke I, Partington P (2009) Blood metal ion concentrations after hip resurfacing arthroplasty: a comparative study of articular surface replacement and Birmingham, hip resurfacing arthroplasties. J Bone Joint Surg Br 91-B:1287–1295
8.
De Haan R, Campbell PA, Su EP, De Smet KA (2008) Revision of metal-on-metal resurfacing arthroplasty of the hip: the influence of malpositioning of the components. J Bone Joint Surg Br 90-B:1158–1163CrossRef
9.
Ollivere B, Darrah C, Barker T, Nolan J, Porteous MJ (2009) Early clinical failure of the Birmingham metal-on-metal hip resurfacing is associated with metallosis and soft tissue necrosis. J Bone Joint Surg Br 91-B:1025–1030CrossRef
10.
Mikhael MM, Hanssen AD, Sierra RJ (2009) Failure of metal-on-metal total hip arthroplasty mimicking hip infection. A report of two cases. J Bone Joint Surg Am 91:443–446PubMedCrossRef
Metadata
Title
Failure of a metal on metal hip prostheses presenting as a destructive soft tissue mass due to ALVAL
Authors
Jonathan R. B. Hutt
Constant Busch
Rod A. Hughes
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1668-y

Other articles of this Issue 10/2011

Rheumatology International 10/2011 Go to the issue

Letter to the Editor

Cholecystokinin octapeptide (CCK-8): friend or foe for rheumatoid arthritis?

Original Article

Feasibility study of semi-automated measurements of finger joint space widths

Editorial

Progress in pediatric rheumatology: apprehend the opportunities of the future without forgetting the lessons from the past

Original Article

The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients

Case Report

Regional migratory osteoporosis: case report of a patient with neuropathic pain

Original Article

A study on the efficacy of treatment with mud packs and baths with Sillene mineral water (Chianciano Spa Italy) in patients suffering from knee osteoarthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits